ToDx,
Hospital-grade testing at home or the clinic
The next step in a
$10B market (2025)
Bringing gold-standard molecular lab testing to wherever it's needed
Bringing gold-standard molecular lab testing to wherever it's needed
Bringing gold-standard molecular lab testing to wherever it's needed
Bringing gold-standard molecular lab testing to wherever it's needed
A critical need. A logical starting point
Our first diagnostic kit:
Sexually transmitted infections
Chlamydia, gonorrhea, and trichomoniasis remain urgent public health challenges. Every day, more than 1 million new infections occur worldwide. In the U.S. alone, about 30 million STI tests are performed annually - yet this still falls short. Many infections go undiagnosed and untreated, fueling continued spread.
Barriers to care are widespread: over 120 million Americans live in healthcare deserts with limited access to testing; results often take days or even weeks, delaying treatment and causing anxiety; stigma and privacy concerns prevent people from seeking help; and high costs ($70–$150 without insurance) discourage testing altogether.
ToDx is developing a lab-quality molecular diagnostic solution that addresses these gaps. Our technology delivers rapid, reliable, and accessible testing at the point of need - whether in clinics or at home - helping improve detection, speed up care, and support better outcomes.
Test anywhere, and get treatment on the same day
Our single-use molecular diagnostic kit detects Chlamydia, Gonorrhea, and Trichomonas within minutes, requiring only a smartphone for result interpretation. With no need for a separate device or electrical sockets and simple operation, patients can test wherever they feel most comfortable.
Ensuring accurate testing with built-in safeguards
Built-in safeguards reduce the risk of errors due to self-sampling errors or mishandling, addressing key concerns for providers and insurers.
The same trusted lab Technology, at home
Leverages the molecular methods behind top-tier lab systems to deliver high sensitivity and specificity at the Point-of-Need
For all genders, from urine, oral and rectal swabs
STIs don’t discriminate—anyone can get infected, and it can happen in different sites of the body. Our test is built to cover it all, with simple samples from urine, oral, and rectal swabs.
STIs are only the beginning
While initially focused on STIs, our technology is adaptable for additional applications such as High risk HPV, respiratory infections, UTIs, and broader syndromic panels, supporting long-term scalability.
Who Benefits from ToDx?
A single, versatile platform that delivers fast, high-accuracy results — while cutting per-test costs by over 50% compared to current point-of-care and mail-in testing.
Patients
No compromises: accurate results on the spot — whether at the point of care or in the comfort and complete privacy of the patient’s home.
Virtual Care Providers
Enables remote diagnosis within existing workflows, supporting timely care and long-term patient engagement.
Retail Clinics & Walk-In Centers
Simplifies operations with fast results, reducing reliance on external labs and improving throughput.
Physician Offices
Empowers clinical decision-making with accurate results during the visit, unlocking reimbursement and streamlining care.
Expert Voices:
Speed of Result
“Result within an hour — amazing.” — Dr. Mor
“Without an answer on the spot it’s bad, that’s obvious to everyone.” — Dr. Meller
Results in minutes are a clear edge.
Our Partners
